333 related articles for article (PubMed ID: 17696767)
1. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons.
Reddy PH
Antioxid Redox Signal; 2007 Oct; 9(10):1647-58. PubMed ID: 17696767
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
3. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
[TBL] [Abstract][Full Text] [Related]
4. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
8. Role of mitochondrial amyloid-beta in Alzheimer's disease.
Chen JX; Yan SS
J Alzheimers Dis; 2010; 20 Suppl 2():S569-78. PubMed ID: 20463403
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?
Leuner K; Hauptmann S; Abdel-Kader R; Scherping I; Keil U; Strosznajder JB; Eckert A; Müller WE
Antioxid Redox Signal; 2007 Oct; 9(10):1659-75. PubMed ID: 17867931
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.
Reddy PH; Beal MF
Trends Mol Med; 2008 Feb; 14(2):45-53. PubMed ID: 18218341
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neurons.
Hu H; Li M
Biochem Biophys Res Commun; 2016 Sep; 478(1):174-180. PubMed ID: 27444386
[TBL] [Abstract][Full Text] [Related]
12. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS
FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
Cardoso SM; Santana I; Swerdlow RH; Oliveira CR
J Neurochem; 2004 Jun; 89(6):1417-26. PubMed ID: 15189344
[TBL] [Abstract][Full Text] [Related]
15. A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
Stockburger C; Miano D; Baeumlisberger M; Pallas T; Arrey TN; Karas M; Friedland K; Müller WE
J Alzheimers Dis; 2016; 50(1):201-15. PubMed ID: 26639968
[TBL] [Abstract][Full Text] [Related]
16. Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease.
Monteiro-Cardoso VF; Oliveira MM; Melo T; Domingues MR; Moreira PI; Ferreiro E; Peixoto F; Videira RA
J Alzheimers Dis; 2015; 43(4):1375-92. PubMed ID: 25182746
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.
Reddy PH; Manczak M; Mao P; Calkins MJ; Reddy AP; Shirendeb U
J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S499-512. PubMed ID: 20413847
[TBL] [Abstract][Full Text] [Related]
18. Multiple defects in energy metabolism in Alzheimer's disease.
Ferreira IL; Resende R; Ferreiro E; Rego AC; Pereira CF
Curr Drug Targets; 2010 Oct; 11(10):1193-206. PubMed ID: 20840064
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
Tyumentsev MA; Stefanova NA; Muraleva NA; Rumyantseva YV; Kiseleva E; Vavilin VA; Kolosova NG
J Alzheimers Dis; 2018; 63(3):1075-1088. PubMed ID: 29710722
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.
Caspersen C; Wang N; Yao J; Sosunov A; Chen X; Lustbader JW; Xu HW; Stern D; McKhann G; Yan SD
FASEB J; 2005 Dec; 19(14):2040-1. PubMed ID: 16210396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
